Despite comparable proliferative activity, Gln-iPSCs consistently developed medulloblastoma, i.e. Gorlin syndrome-associated tumor, with secondary somatic mutations of the PTCH1 gene. The gene discussed is PTCH1; the disease is medulloblastoma.